Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted Covalent Inhibitors for Drug Design
Thomas A. Baillie
Angewandte Chemie International Edition (2016) Vol. 55, Iss. 43, pp. 13408-13421
Closed Access | Times Cited: 476

Showing 1-25 of 476 citing articles:

Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology
Matthias Gehringer, Stefan Laufer
Journal of Medicinal Chemistry (2018) Vol. 62, Iss. 12, pp. 5673-5724
Closed Access | Times Cited: 581
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease
A. Douangamath, D. Fearon, Paul Gehrtz, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 486
An Activity-Guided Map of Electrophile-Cysteine Interactions in Primary Human T Cells
Ekaterina V. Vinogradova, Xiaoyu Zhang, David Remillard, et al.
Cell (2020) Vol. 182, Iss. 4, pp. 1009-1026.e29
Open Access | Times Cited: 286
Rapid Covalent-Probe Discovery by Electrophile-Fragment Screening
Efrat Resnick, A.R. Bradley, Jinrui Gan, et al.
Journal of the American Chemical Society (2019) Vol. 141, Iss. 22, pp. 8951-8968
Open Access | Times Cited: 280
Covalent inhibitors design and discovery
Stéphane De Cesco, Jerry Kurian, Caroline Dufresne, et al.
European Journal of Medicinal Chemistry (2017) Vol. 138, pp. 96-114
Closed Access | Times Cited: 271
Advances in covalent kinase inhibitors
Ayah Abdeldayem, Yasir S. Raouf, Stefan N. Constantinescu, et al.
Chemical Society Reviews (2020) Vol. 49, Iss. 9, pp. 2617-2687
Closed Access | Times Cited: 256
Fibroblast Growth Factor Receptors (FGFRs): Structures and Small Molecule Inhibitors
Shuyan Dai, Zhan Zhou, Zhuchu Chen, et al.
Cells (2019) Vol. 8, Iss. 6, pp. 614-614
Open Access | Times Cited: 242
Covalent Inhibition in Drug Discovery
Avick Kumar Ghosh, Indranil Samanta, Anushree Mondal, et al.
ChemMedChem (2019) Vol. 14, Iss. 9, pp. 889-906
Open Access | Times Cited: 223
The Cysteinome of Protein Kinases as a Target in Drug Development
A. Chaikuad, Pierre Koch, Stefan Laufer, et al.
Angewandte Chemie International Edition (2017) Vol. 57, Iss. 16, pp. 4372-4385
Closed Access | Times Cited: 220
A Perspective on Multi-target Drugs for Alzheimer’s Disease
Ondřej Benek, Jan Korábečný, Ondřej Soukup
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 7, pp. 434-445
Closed Access | Times Cited: 204
Lysine‐Targeting Covalent Inhibitors
Jonathan Pettinger, Keith Jones, Matthew D. Cheeseman
Angewandte Chemie International Edition (2017) Vol. 56, Iss. 48, pp. 15200-15209
Closed Access | Times Cited: 196
Rapid labelling and covalent inhibition of intracellular native proteins using ligand-directed N-acyl-N-alkyl sulfonamide
Tomonori Tamura, Tsuyoshi Ueda, Taiki Goto, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 193
Progress with covalent small-molecule kinase inhibitors
Zheng Zhao, Philip E. Bourne
Drug Discovery Today (2018) Vol. 23, Iss. 3, pp. 727-735
Open Access | Times Cited: 185
A Heck–Matsuda Process for the Synthesis of β‐Arylethenesulfonyl Fluorides: Selectively Addressable Bis‐electrophiles for SuFEx Click Chemistry
Hua‐Li Qin, Qinheng Zheng, Grant A. L. Bare, et al.
Angewandte Chemie International Edition (2016) Vol. 55, Iss. 45, pp. 14155-14158
Open Access | Times Cited: 172
Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 135
The Ascension of Targeted Covalent Inhibitors
Juswinder Singh
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 8, pp. 5886-5901
Closed Access | Times Cited: 130
Bruton tyrosine kinase inhibitors for multiple sclerosis
Julia Krämer, Amit Bar‐Or, Timothy J. Turner, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 5, pp. 289-304
Open Access | Times Cited: 99
Potent and selective covalent inhibition of the papain-like protease from SARS-CoV-2
Brian Sanders, Suman Pokhrel, Audrey Labbé, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 63
Recent Advances in Covalent Drug Discovery
D. M. Schaefer, Xinlai Cheng
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 663-663
Open Access | Times Cited: 45
Advancements and novel approaches in modified AutoDock Vina algorithms for enhanced molecular docking
Arkadeep Sarkar, Simona Concilio, Lucia Sessa, et al.
Results in Chemistry (2024) Vol. 7, pp. 101319-101319
Open Access | Times Cited: 21
Expanding the Armory: Predicting and Tuning Covalent Warhead Reactivity
Richard Lonsdale, Jonathan Burgess, Nicola Colclough, et al.
Journal of Chemical Information and Modeling (2017) Vol. 57, Iss. 12, pp. 3124-3137
Closed Access | Times Cited: 156
Development of an Acrylate Derivative Targeting the NLRP3 Inflammasome for the Treatment of Inflammatory Bowel Disease
Mattia Cocco, Carolina Pellegrini, Helios Martínez‐Banaclocha, et al.
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 9, pp. 3656-3671
Open Access | Times Cited: 152
ERK1/2 inhibitors: New weapons to inhibit the RAS-regulated RAF-MEK1/2-ERK1/2 pathway
Andrew M. Kidger, James Sipthorp, Simon J. Cook
Pharmacology & Therapeutics (2018) Vol. 187, pp. 45-60
Open Access | Times Cited: 146
Arylfluorosulfate‐Based Electrophiles for Covalent Protein Labeling: A New Addition to the Arsenal
Pablo Martín‐Gago, Christian A. Olsen
Angewandte Chemie International Edition (2018) Vol. 58, Iss. 4, pp. 957-966
Open Access | Times Cited: 142
The Symbiotic Relationship Between Drug Discovery and Organic Chemistry
Oleksandr O. Grygorenko, Dmitriy M. Volochnyuk, Sergey V. Ryabukhin, et al.
Chemistry - A European Journal (2019) Vol. 26, Iss. 6, pp. 1196-1237
Closed Access | Times Cited: 141
Page 1 - Next Page

Scroll to top